Clinical Trial Update: Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of RBD5044 in patients with mixed dyslipidemia; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• RBD5044

Snippet

Sponsor: Ribocure Pharmaceuticals AB | Conditions: Dyslipidemias | Phase 2 | Status: RECRUITING